Nathan Alan Pease

Title: Nathan Alan Pease: Innovator in Antibody-Drug Conjugates

Introduction

Nathan Alan Pease is a notable inventor based in Bloomington, IN (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody-drug conjugates (ADCs). His innovative work focuses on improving the formulations of these conjugates to enhance their efficacy and stability.

Latest Patents

Nathan Alan Pease holds a patent for "Lyophilized anti-tissue factor antibody-drug conjugates." This patent discloses surfactant-free lyophilized formulations of ADCs, specifically targeting anti-tissue factor ADCs. The formulations are designed to be particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drugs. The excipients used in these formulations typically include histidine, sucrose, trehalose, mannitol, and glycine.

Career Highlights

Throughout his career, Nathan has demonstrated a strong commitment to advancing the field of biopharmaceuticals. His work at Genmab A/S has positioned him as a key player in the development of innovative therapeutic solutions. His research has the potential to significantly impact the treatment of various diseases.

Collaborations

Nathan has collaborated with esteemed colleagues such as Jesper Valbjørn and Xiaona Jing. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Nathan Alan Pease is a distinguished inventor whose work in antibody-drug conjugates exemplifies innovation in the biopharmaceutical industry. His contributions are paving the way for more effective treatments and improved patient outcomes.